Zhejiang CONBA Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2021: 0.02%

Zhejiang CONBA Pharmaceutical Co Ltd (600572) has an Asset Resilience Ratio of 0.02% as of March 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 600572 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥1.80 Million

≈ $262.70K USD Cash + Short-term Investments

Total Assets

CN¥8.92 Billion

≈ $1.31 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2020)

This chart shows how Zhejiang CONBA Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Zhejiang CONBA Pharmaceutical Co Ltd (600572) net asset quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang CONBA Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Zhejiang CONBA Pharmaceutical Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.80 Million	0.02%
Total Liquid Assets	CN¥1.80 Million	0.02%

Asset Resilience Insights

Limited Liquidity: Zhejiang CONBA Pharmaceutical Co Ltd maintains only 0.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang CONBA Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang CONBA Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	0.76%
Eris Lifesciences Limited NSE:ERIS	Drug Manufacturers - Specialty & Generic	0.58%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%
Lotus Pharmaceutical Co Ltd TW:1795	Drug Manufacturers - Specialty & Generic	0.49%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Sun Pharma Advanced Research Company Limited NSE:SPARC	Drug Manufacturers - Specialty & Generic	0.64%

Annual Asset Resilience Ratio for Zhejiang CONBA Pharmaceutical Co Ltd (2001–2020)

The table below shows the annual Asset Resilience Ratio data for Zhejiang CONBA Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2020-12-31	0.02%	CN¥1.80 Million ≈ $262.70K	CN¥9.28 Billion ≈ $1.36 Billion	-0.11pp
2019-12-31	0.13%	CN¥13.04 Million ≈ $1.91 Million	CN¥9.86 Billion ≈ $1.44 Billion	-0.38pp
2018-12-31	0.51%	CN¥54.87 Million ≈ $8.03 Million	CN¥10.71 Billion ≈ $1.57 Billion	-1.02pp
2017-12-31	1.53%	CN¥144.02 Million ≈ $21.07 Million	CN¥9.42 Billion ≈ $1.38 Billion	+0.69pp
2016-12-31	0.84%	CN¥71.48 Million ≈ $10.46 Million	CN¥8.50 Billion ≈ $1.24 Billion	+0.01pp
2015-12-31	0.83%	CN¥79.23 Million ≈ $11.59 Million	CN¥9.57 Billion ≈ $1.40 Billion	+0.74pp
2014-12-31	0.09%	CN¥5.50 Million ≈ $804.82K	CN¥6.30 Billion ≈ $921.72 Million	+0.08pp
2008-12-31	0.00%	CN¥64.05K ≈ $9.37K	CN¥1.57 Billion ≈ $229.63 Million	-0.06pp
2007-12-31	0.06%	CN¥935.55K ≈ $136.90K	CN¥1.55 Billion ≈ $226.53 Million	+0.04pp
2006-12-31	0.02%	CN¥240.44K ≈ $35.18K	CN¥1.26 Billion ≈ $183.77 Million	+0.00pp
2005-12-31	0.01%	CN¥171.72K ≈ $25.13K	CN¥1.16 Billion ≈ $169.10 Million	0.00pp
2004-12-31	0.02%	CN¥167.78K ≈ $24.55K	CN¥981.41 Million ≈ $143.61 Million	-0.01pp
2003-12-31	0.03%	CN¥174.31K ≈ $25.51K	CN¥581.65 Million ≈ $85.11 Million	-0.03pp
2002-12-31	0.06%	CN¥269.97K ≈ $39.51K	CN¥462.63 Million ≈ $67.70 Million	-0.21pp
2001-12-31	0.27%	CN¥1.22 Million ≈ $178.61K	CN¥447.63 Million ≈ $65.50 Million	--

pp = percentage points

About Zhejiang CONBA Pharmaceutical Co Ltd

SHG:600572 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.53 Billion

CN¥10.45 Billion CNY

Market Cap Rank

#7296 Global

#1676 in China

Share Price

CN¥4.12

Change (1 day)

+0.24%

52-Week Range

CN¥4.06 - CN¥4.94

All Time High

CN¥10.42